ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01611090
Brief Title: A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

First Submitted : May 15, 2012
First Submitted that Met QC Criteria : May 31, 2012
First Posted : June 4, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : February 18, 2019
Last Update Posted : February 19, 2019